Intelligence Platform
Patents
Browse 565 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11648211
Nanoencapsulated combination drug formulations
granted patentUS 11633503
Delivery of oligonucleotide-functionalized nanoparticles
granted patentUS 11624125
Stabilization of colloidal crystals engineered with nucleic acid
granted patentUS 11613754
Toxic RNAi active seed sequences for killing cancer cells
granted patentUS 11607462
Systems and methods for minimally-invasive assessment of toxicity-induced tissue injury
granted patentUS 11566224
Dendritic cell generator
granted patentUS 11566016
MAP kinase modulators and uses thereof
granted patentUS 11559609
Bone-promoting thermoresponsive macromolecules
granted patentUS 11560414
Kits comprising myokines and platinum-based chemotherapeutic agents for treating colorecta
granted patentUS 11559556
Citrus fruit extract-mediated synthesis of tellurium nanomaterials having biomedical appli
granted patentUS 11554103
Compositions and methods to reduce pharmaceutical-induced toxicity
granted patentUS 11541086
Compositions and methods for treating Alzheimer's disease
granted patentUS 11542538
Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glyco
granted patentUS 11535648
Isolated darobactin A analog compounds and compositions thereof
granted patentUS 11529417
Wound healing through sirt1 overexpression
granted patentUS 11530432
Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro vi
granted patentUS 11518750
3-methylideneoxan-4-one compounds and substituted derivatives thereof as inhibitors of tel
granted patentUS 11517648
Nanofiber paste for growth factor delivery and bone regeneration
granted patentUS 11510872
Nanoparticle-lipid composite carriers and uses thereof
granted patentUS 11497713
Combination taxoid nanoemulsion with immunotherapy in cancer
granted patentUS 11497788
Supramolecular glycosaminoglycans
granted patentUS 11491231
Peptide-oligonucleotide chimeras (POCs) as programmable biomolecular constructs for the as
granted patentUS 11485734
Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2C (5-HT
granted patentUS 11464719
Cosmetic and dermatological compositions
granted